ICOS and neoplasm: We have recently found that the growth of established mouse melanoma is inhibited by treatment with ICOS-Fc, a recombinant water-soluble ICOS protein, when it is loaded into either biocompatible poly(lactic-co-glycolic acid) (PLGA) or cyclodextrin nanoparticles, which are able to target the drug to the tumor mass [4].